lapatinib has been researched along with sitagliptin phosphate in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (sitagliptin phosphate) | Trials (sitagliptin phosphate) | Recent Studies (post-2010) (sitagliptin phosphate) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 1,715 | 471 | 1,390 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| AlAjmi, MF; Hussain, A; Rehman, MT | 1 |
1 other study(ies) available for lapatinib and sitagliptin phosphate
| Article | Year |
|---|---|
Celecoxib, Glipizide, Lapatinib, and Sitagliptin as potential suspects of aggravating SARS-CoV-2 (COVID-19) infection: a computational approach.
Topics: Angiotensin-Converting Enzyme 2; Celecoxib; COVID-19; Glipizide; Humans; Lapatinib; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; SARS-CoV-2; Sitagliptin Phosphate | 2022 |